Literature DB >> 23070619

Role of community pharmacists in the prevention and management of the metabolic syndrome in Kuwait.

Maram G Katoue1, Abdelmoneim I Awad, Samuel B Kombian.   

Abstract

BACKGROUND: The metabolic syndrome is a cluster of cardiovascular risk factors and its prevalence is alarmingly high in Kuwait, affecting nearly one third of the adult population. There is lack of information about the role of community pharmacists in the care of patients with the metabolic syndrome.
OBJECTIVE: To assess the awareness and opinions of community pharmacists about the metabolic syndrome and identify the services they provide for identification, management and monitoring of patients with the metabolic syndrome.
SETTING: Community pharmacies in Kuwait.
METHOD: A descriptive, cross-sectional study was performed on a randomly selected sample of 225 community pharmacists. Data were collected via face-to-face structured interview of the pharmacists using a pre-tested questionnaire. MAIN OUTCOME MEASURES: Pharmacists' knowledge and views on the metabolic syndrome, monitoring services provided, self-reported practices and perceived effectiveness of the various management interventions for the metabolic syndrome.
RESULTS: The response rate was 97.8 %. Nine pharmacists claimed to know about the metabolic syndrome, but only one pharmacist could identify the condition correctly. After being given a definition of the metabolic syndrome, 67.7 % of respondents strongly agreed that its prevalence was rising in Kuwait. Nearly two thirds of respondents reported providing height and weight measurement service while 82.7 and 59.5 % of pharmacies provided blood pressure and blood glucose measurements, respectively. Waist circumference and lipid profile measurements were the least provided services (1.8 %). Respondents claimed to be involved in counseling patients on lifestyle modifications including increased exercise (98.1 %) and weight reduction through diet (96.9 %). Most pharmacists were involved in encouraging patients' adherence with prescribed treatments (98.6 %) and perceived these as the most effective intervention for the management of the metabolic syndrome (95.0 %). Respondents were less involved in monitoring patients' response to therapy (75.0 %) and documenting patient care services (5.0 %).
CONCLUSION: This study revealed significant deficits in awareness among community pharmacists about the metabolic syndrome. Given the proper education and training, community pharmacists could be important front-line contributors to the control of this emerging epidemic in Kuwait.

Entities:  

Mesh:

Year:  2012        PMID: 23070619     DOI: 10.1007/s11096-012-9705-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


  30 in total

1.  Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus).

Authors:  Ross T Tsuyuki; Kari L Olson; Alexander M Dubyk; Terri J Schindel; Jeffrey A Johnson
Journal:  Am J Med       Date:  2004-01-15       Impact factor: 4.965

2.  Enhancing pharmacist involvement in weight management--time to get with the program.

Authors:  Margaret Malone
Journal:  Ann Pharmacother       Date:  2004-09-28       Impact factor: 3.154

3.  Health promotion and education activities of community pharmacists in Kuwait.

Authors:  Abdelmoneim Awad; Eman Abahussain
Journal:  Pharm World Sci       Date:  2009-12-29

4.  The relationship of percent body fat by bioelectrical impedance analysis with blood pressure, and glucose and lipid parameters.

Authors:  Junji Kobayashi; Shunichi Murano; Isao Kawamura; Fumie Nakamura; Yuko Murase; Masa-Aki Kawashiri; Atsushi Nohara; Akimichi Asano; Akihiro Inazu; Hiroshi Mabuchi
Journal:  J Atheroscler Thromb       Date:  2006-10       Impact factor: 4.928

5.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

6.  A randomized controlled trial of a smoking cessation intervention based in community pharmacies.

Authors:  T A Maguire; J C McElnay; A Drummond
Journal:  Addiction       Date:  2001-02       Impact factor: 6.526

7.  National survey of pharmacists about coronary heart disease, hypercholesterolemia, nonprescription statintherapy, and pharmacists' services.

Authors:  James M McKenney; J Chris Bradberry; Robert L Talbert; Edward Cahill; W Virgil Brown
Journal:  J Am Pharm Assoc (2003)       Date:  2004 Sep-Oct

8.  Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.

Authors:  Rosalind Lau; Kay Stewart; Kevin P McNamara; Shane L Jackson; Jeffery D Hughes; Gregory M Peterson; Diana A Bortoletto; Jenny McDowell; Michael J Bailey; Arthur Hsueh; Johnson George
Journal:  BMC Health Serv Res       Date:  2010-02-05       Impact factor: 2.655

9.  Prevalence of overweight, obesity, and metabolic syndrome among adult Kuwaitis: results from community-based national survey.

Authors:  Ibrahim Al Rashdan; Yousef Al Nesef
Journal:  Angiology       Date:  2009-04-26       Impact factor: 3.619

10.  The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.

Authors:  I Krass; C L Armour; B Mitchell; M Brillant; R Dienaar; J Hughes; P Lau; G Peterson; K Stewart; S Taylor; J Wilkinson
Journal:  Diabet Med       Date:  2007-06       Impact factor: 4.359

View more
  4 in total

1.  A cross sectional study on beliefs and roles of community pharmacy professionals in preventing and managing metabolic syndrome in an Ethiopian setting.

Authors:  Sewunet Admasu Belachew; Niguse Yigzaw Muluneh; Daniel Asfaw Erku; Adeladlew Kassie Netere
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

2.  Multicenter Cross-Sectional Study on Perceptions and Roles of Community Pharmacists in the Prevention and Management of Cardiovascular Disorders in Northwest Ethiopia.

Authors:  Ashenafi Kibret Sendekie; Adeladlew Kassie Netere
Journal:  Integr Pharm Res Pract       Date:  2022-01-19

3.  Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study.

Authors:  Maria Angeles Via-Sosa; Cristina Toro; Pere Travé; Marian A March
Journal:  BMC Public Health       Date:  2014-05-22       Impact factor: 3.295

4.  Pharmaceutical care education in Kuwait: pharmacy students' perspectives.

Authors:  Maram G Katoue; Abdelmoneim I Awad; Terry L Schwinghammer; Samuel B Kombian
Journal:  Pharm Pract (Granada)       Date:  2014-09-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.